Ken Griffin Sesen Bio, Inc. Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.49 - $0.61 $519 - $646	-1,060 Reduced 4.59%	22,034 $13,000
Q3 2022 Nov 14, 2022	BUY	$0.0 - $0.93 $0 - $21,477	23,094 New	23,094 $10,000
Q1 2022 May 16, 2022	SELL	$0.58 - $0.86 $334,144 - $495,455	-576,111 Reduced 83.92%	110,389 $67,000
Q4 2021 Feb 14, 2022	BUY	$0.73 - $1.28 $201,756 - $353,765	276,379 Added 67.39%	686,500 $562,000
Q3 2021 Nov 15, 2021	BUY	$0.77 - $4.91 $254,943 - $1.63 Million	331,096 Added 418.98%	410,121 $325,000
Q2 2021 Aug 16, 2021	SELL	$2.18 - $4.66 $500,006 - $1.07 Million	-229,361 Reduced 74.37%	79,025 $365,000
Q1 2021 May 17, 2021	BUY	$1.3 - $3.24 $320,569 - $798,958	246,592 Added 399.05%	308,386 $802,000
Q4 2020 Feb 16, 2021	SELL	$1.01 - $1.77 $72,005 - $126,188	-71,293 Reduced 53.57%	61,794 $83,000
Q3 2020 Nov 16, 2020	BUY	$0.67 - $1.4 $28,363 - $59,267	42,334 Added 46.65%	133,087 $187,000
Q2 2020 Aug 14, 2020	BUY	$0.52 - $0.87 $5,228 - $8,746	10,054 Added 12.46%	90,753 $65,000
Q1 2020 May 15, 2020	SELL	$0.39 - $1.03 $7,089 - $18,724	-18,179 Reduced 18.39%	80,699 $45,000
Q4 2019 Feb 14, 2020	BUY	$0.89 - $1.5 $68,679 - $115,752	77,168 Added 355.45%	98,878 $103,000
Q3 2019 Nov 14, 2019	SELL	$1.04 - $1.51 $28,981 - $42,079	-27,867 Reduced 56.21%	21,710 $25,000
Q2 2019 Aug 14, 2019	BUY	$0.95 - $2.46 $31,867 - $82,520	33,545 Added 209.24%	49,577 $74,000
Q1 2019 May 15, 2019	SELL	$0.69 - $1.47 $17,619 - $37,536	-25,535 Reduced 61.43%	16,032 $0
Q4 2018 Feb 14, 2019	BUY	$0.96 - $2.04 $23,015 - $48,906	23,974 Added 136.27%	41,567 $59,000
Q3 2018 Nov 13, 2018	SELL	$1.54 - $2.38 $43,233 - $66,816	-28,074 Reduced 61.48%	17,593 $0
Q2 2018 Aug 10, 2018	BUY	$1.04 - $3.29 $47,493 - $150,244	45,667 New	45,667 $0

Others Institutions Holding SESN

# of Institutions

Shares Held

Call Options Held

Put Options Held

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About Sesen Bio, Inc.

Ticker SESN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,702,000
Market Cap $127M
Description
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...

More about SESN

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account